Access to mental healthcare is more important than ever.
During the first year of the Covid-19 pandemic, global anxiety and depression rates increased by 25%. Meanwhile, 42% of Americans who reported needing mental healthcare over the past 12 months did not get it because of low availability and affordability.
DOWNLOAD THE STATE OF DIGITAL HEALTH Q3’22 REPORT
Want the full post? Become a CB Insights customer.
If you’re already a customer, log in here.
The post What are Pfizer, Johnson & Johnson, and Sanofi doing in mental health? appeared first on CB Insights Research.